Альманах клинической медицины. 2014; : 37-45
ССЛЕДОВАНИЕ АЛЬБУМИНУРИИ КАК МАРКЕРА ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У ВЗРОСЛОГО ТРУДОСПОСОБНОГО НАСЕЛЕНИЯ
https://doi.org/10.18786/2072-0505-2014-30-37-45Аннотация
Список литературы
1. Антонова Т.Н., Бикбов Б.Т., Галь И.Г., Томилина H.A. К вопросу о распространенности хронической болезни почек среди пожилых лиц в г. Москве и ее связи с сердечно-сосудистой патологией//Нефрол. и диализ. 2011. N93. С.353-354.
2. Добронравов В.А., Смирнов A.B., Каюков И.Г. и др. Многогранная альбуминурия: аспекты клинического значения//Нефрология. 2009. N93. С.33-38.
3. Мухин H.A., Моисеев B.C., Кобалава Ж.Д. и др. Кардиоренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек//Тер. арх. 2004. N96. С.39-46.
4. Нагайцева С.С., Швецов М.Ю., Шалягин Ю.Д. и др. Оценка альбуминурии методом тест-полосок с целью раннего выявления хронической болезни почек у лиц с разной степенью риска (опыт Центров здоровья Московской области)//Тер. арх. 2013. №6. С.38-43.
5. Серов В.А., Шутов А.М., Хитева С.В. и др. Возрастные и гендерные особенности распространенности хронической болезни почек среди больных с хронической сердечной недостаточностью//Нефрол. и диализ. 2009. N94. С.332-335.
6. Смирнов A.B., Добронравов В.А., Каюков И.Г. и др. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Национальные рекомендации//Нефрология. 2012. N91. С.89-115.
7. Шалягин Ю.Д., Нагайцева С.С., Швецов М.Ю., Лукшина Л.П. и др. Снижение скорости клубочковой фильтрации как маркер хронической болезни почек: частота встречаемости и клинические ассоциации (по данным обследования пациентов терапевтического профиля, госпитализированных в Коломенскую ЦРБ)//Сб. тезисов VII съезда Научного общества нефрологов России. М., 2010. С.140-141.
8. Atkins R.C. The epidemiology of chronic kidney disease//Kidney Int. 2005. V.67, No.94. P.14-18.
9. Bommer J. Prevalence and socio-economic aspects of chronic kidney disease//Nephrol. Dial. Transplant. 2002. V.17 (Suppl.), No.11. P.8-12.
10. Chadban S.J., Briganti E.M., Kerr P.G. et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study//J. Am. Soc. Nephrol. 2003. V.14 (Suppl.2). P.131-138.
11. Cirillo M., Stellato D., Laurenzi M. et al. Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group//Kidney Int. 2000. V.58. P.1211-1218.
12. Coresh J., Astor B.C., Green T. et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey//Am. J. Kidney Dis. 2003. V.41. P.l-12.
13. Couser W.G., Remuzzi G., Mendis S., Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases//Kidney Int. 2011. V.80. P.1258-1270.
14. Crowe E., Halpin D., Stevens P. NICE guideline: Early identification and management of chronic kidney disease//Brit. Med. J. 2008. V. 337. P.1136-1145.
15. De Jong P.E., Verhave J.C., Pinto-Siestma S.J. et al. Obesity and target organ damage: the kidney//Int. J. Obes. Relat. Metab. Disord. 2002. V.26, No.4. P.21-24.
16. Gilbetr R., Phillips Р., Jerums G. Relationship between ambulatory blood pressure and albuminuria in normal subjects//Am. J. Hypertens. 1991. No.4. P.959-962.
17. Hallan S.I., Coresh J., Astor B.C. et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk//J. Am. Soc. Nephrol. 2006. V.17. P.2275-2284.
18. Haroun N.K., Jaar B.G., Hoffman S.C. et al. Risk factors for chronic Kidney disease: a prospective study of 23, 534 men and women in Washington Country, Maryland//J. Am. Soc. Nephrol. 2003. V.14. P.2934-2941.
19. KDIGO. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease//Kidney Int. 2013. V.3, No.l. P.l-150.
20. Levey A.S., Coresh J., Balk E., Kausz A.T. et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification and stratification//Ann. Intern. Med. 2003. V.139. P.137-147.
21. Lotan Y., Daudon M., Bruyère F. et al. Impact of fluid intake in the prevention of urinary system diseases: a brief review//Curr. Opin. Nephrol. Hypertens. 2013. V.22, No.l. P.l-10.
22. National Kidney Foundation: K/DOQJ clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification//Am. J. Kidney Dis. 2002. V.39. P.l-266.
23. Orth S.R. Smoking and the kidney//J. Am. Soc. Nephrol. 2002. V.13. P.1663-1672.
24. Perdinelli R. Microalbuminuria in Hypertension//Nephron. 1996. V.73. P.499-505.
25. Pinto-Siersma S.J., Mulder J., Janssen W.M. et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons//Ann. Intern. Med. 2000. V.133. P.585-591.
26. Qaseem A., Hopkins R.H., Sweet D.E. et al. Screening, Monitoring and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the Clinical Guidelines Committee of the American College of Physicians//Ann. Intern. Med. 2013. V.159, No.12. P.835-847.
27. Ritz E. Hypertension and kidney disease//Clin. Nephrol. 2010. V.74. Suppl. 1. P.39-43.
28. Schaeffher E.S., Kurth T., Curhan G.C. et al. Cholesterol and the risk of renal dysfunction in apparently healthy men//J. Am. Soc. Nephrol. 2003. V.14. P.2084-2091.
29. Sontrop J.M., Dixon S.N., Garg A.X. et al. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data//Am. J. Nephrol. 2013. V.37, №5. P.434-442.
30. Stengel B., Tarver C.M., Powe N.R. et al. Lifestyle factors, obesity and the risk of chronic kidney disease//Epidemiology. 2003. V.14, No.4. P.479-487.
31. Stuveling E.M., Bakker S.J., Hilige H.X. et al. Biochemical risk markers: a novel area for better prediction of renal risk?//Nephrol. Dial. Transplant. 2005. V.20. P.497-508.
32. Verhave J.C., Hillege H.Z., Burgerhof G.M. et al. The association between atherosclerotic risk factors and renal function in the general population//Kidney Int. 2005. V.67. P.1967-1973.
33. Warmoth L., Regalado M.M., Simoni J. et al. Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension//Am. J. Med. Sei. 2005. V.330, No.3. P.lll-119.
34. Zavie C.J., Milani R.V. Obesity and cardiovascular disease: the Hyppocrates paradox?//J. Am. Coll. Cardiol. 2003. V.42. P.677-679.
35. Zhang Q-L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review//BMC Public Health. 2008. V.8. P.117-124.
Almanac of Clinical Medicine. 2014; : 37-45
ASSESSMENT OF ALBUMINURIA AS A MARKER OF CHRONIC KIDNEY DISEASE IN ADULT WORKING POPULATION
https://doi.org/10.18786/2072-0505-2014-30-37-45References
1. Antonova T.N., Bikbov B.T., Gal' I.G., Tomilina H.A. K voprosu o rasprostranennosti khronicheskoi bolezni pochek sredi pozhilykh lits v g. Moskve i ee svyazi s serdechno-sosudistoi patologiei//Nefrol. i dializ. 2011. N93. S.353-354.
2. Dobronravov V.A., Smirnov A.B., Kayukov I.G. i dr. Mnogogrannaya al'buminuriya: aspekty klinicheskogo znacheniya//Nefrologiya. 2009. N93. S.33-38.
3. Mukhin H.A., Moiseev B.C., Kobalava Zh.D. i dr. Kardiorenal'nye vzaimodeistviya: klinicheskoe znachenie i rol' v patogeneze zabolevanii serdechno-sosudistoi sistemy i pochek//Ter. arkh. 2004. N96. S.39-46.
4. Nagaitseva S.S., Shvetsov M.Yu., Shalyagin Yu.D. i dr. Otsenka al'buminurii metodom test-polosok s tsel'yu rannego vyyavleniya khronicheskoi bolezni pochek u lits s raznoi stepen'yu riska (opyt Tsentrov zdorov'ya Moskovskoi oblasti)//Ter. arkh. 2013. №6. S.38-43.
5. Serov V.A., Shutov A.M., Khiteva S.V. i dr. Vozrastnye i gendernye osobennosti rasprostranennosti khronicheskoi bolezni pochek sredi bol'nykh s khronicheskoi serdechnoi nedostatochnost'yu//Nefrol. i dializ. 2009. N94. S.332-335.
6. Smirnov A.B., Dobronravov V.A., Kayukov I.G. i dr. Khronicheskaya bolezn' pochek: osnovnye printsipy skrininga, diagnostiki, profilaktiki i podkhody k lecheniyu. Natsional'nye rekomendatsii//Nefrologiya. 2012. N91. S.89-115.
7. Shalyagin Yu.D., Nagaitseva S.S., Shvetsov M.Yu., Lukshina L.P. i dr. Snizhenie skorosti klubochkovoi fil'tratsii kak marker khronicheskoi bolezni pochek: chastota vstrechaemosti i klinicheskie assotsiatsii (po dannym obsledovaniya patsientov terapevticheskogo profilya, gospitalizirovannykh v Kolomenskuyu TsRB)//Sb. tezisov VII s\"ezda Nauchnogo obshchestva nefrologov Rossii. M., 2010. S.140-141.
8. Atkins R.C. The epidemiology of chronic kidney disease//Kidney Int. 2005. V.67, No.94. P.14-18.
9. Bommer J. Prevalence and socio-economic aspects of chronic kidney disease//Nephrol. Dial. Transplant. 2002. V.17 (Suppl.), No.11. P.8-12.
10. Chadban S.J., Briganti E.M., Kerr P.G. et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study//J. Am. Soc. Nephrol. 2003. V.14 (Suppl.2). P.131-138.
11. Cirillo M., Stellato D., Laurenzi M. et al. Pulse pressure and isolated systolic hypertension: association with microalbuminuria. The GUBBIO Study Collaborative Research Group//Kidney Int. 2000. V.58. P.1211-1218.
12. Coresh J., Astor B.C., Green T. et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey//Am. J. Kidney Dis. 2003. V.41. P.l-12.
13. Couser W.G., Remuzzi G., Mendis S., Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases//Kidney Int. 2011. V.80. P.1258-1270.
14. Crowe E., Halpin D., Stevens P. NICE guideline: Early identification and management of chronic kidney disease//Brit. Med. J. 2008. V. 337. P.1136-1145.
15. De Jong P.E., Verhave J.C., Pinto-Siestma S.J. et al. Obesity and target organ damage: the kidney//Int. J. Obes. Relat. Metab. Disord. 2002. V.26, No.4. P.21-24.
16. Gilbetr R., Phillips R., Jerums G. Relationship between ambulatory blood pressure and albuminuria in normal subjects//Am. J. Hypertens. 1991. No.4. P.959-962.
17. Hallan S.I., Coresh J., Astor B.C. et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk//J. Am. Soc. Nephrol. 2006. V.17. P.2275-2284.
18. Haroun N.K., Jaar B.G., Hoffman S.C. et al. Risk factors for chronic Kidney disease: a prospective study of 23, 534 men and women in Washington Country, Maryland//J. Am. Soc. Nephrol. 2003. V.14. P.2934-2941.
19. KDIGO. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease//Kidney Int. 2013. V.3, No.l. P.l-150.
20. Levey A.S., Coresh J., Balk E., Kausz A.T. et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification and stratification//Ann. Intern. Med. 2003. V.139. P.137-147.
21. Lotan Y., Daudon M., Bruyère F. et al. Impact of fluid intake in the prevention of urinary system diseases: a brief review//Curr. Opin. Nephrol. Hypertens. 2013. V.22, No.l. P.l-10.
22. National Kidney Foundation: K/DOQJ clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification//Am. J. Kidney Dis. 2002. V.39. P.l-266.
23. Orth S.R. Smoking and the kidney//J. Am. Soc. Nephrol. 2002. V.13. P.1663-1672.
24. Perdinelli R. Microalbuminuria in Hypertension//Nephron. 1996. V.73. P.499-505.
25. Pinto-Siersma S.J., Mulder J., Janssen W.M. et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons//Ann. Intern. Med. 2000. V.133. P.585-591.
26. Qaseem A., Hopkins R.H., Sweet D.E. et al. Screening, Monitoring and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the Clinical Guidelines Committee of the American College of Physicians//Ann. Intern. Med. 2013. V.159, No.12. P.835-847.
27. Ritz E. Hypertension and kidney disease//Clin. Nephrol. 2010. V.74. Suppl. 1. P.39-43.
28. Schaeffher E.S., Kurth T., Curhan G.C. et al. Cholesterol and the risk of renal dysfunction in apparently healthy men//J. Am. Soc. Nephrol. 2003. V.14. P.2084-2091.
29. Sontrop J.M., Dixon S.N., Garg A.X. et al. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data//Am. J. Nephrol. 2013. V.37, №5. P.434-442.
30. Stengel B., Tarver C.M., Powe N.R. et al. Lifestyle factors, obesity and the risk of chronic kidney disease//Epidemiology. 2003. V.14, No.4. P.479-487.
31. Stuveling E.M., Bakker S.J., Hilige H.X. et al. Biochemical risk markers: a novel area for better prediction of renal risk?//Nephrol. Dial. Transplant. 2005. V.20. P.497-508.
32. Verhave J.C., Hillege H.Z., Burgerhof G.M. et al. The association between atherosclerotic risk factors and renal function in the general population//Kidney Int. 2005. V.67. P.1967-1973.
33. Warmoth L., Regalado M.M., Simoni J. et al. Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension//Am. J. Med. Sei. 2005. V.330, No.3. P.lll-119.
34. Zavie C.J., Milani R.V. Obesity and cardiovascular disease: the Hyppocrates paradox?//J. Am. Coll. Cardiol. 2003. V.42. P.677-679.
35. Zhang Q-L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review//BMC Public Health. 2008. V.8. P.117-124.
